The China plus one strategy encourages diversification of suppliers due to geopolitical risks, which benefits Indian companies across various sectors. In pharma, both traditional and CDMO segments show opportunities. The industrial sector grows more attractive as interest rates drop and currency stabilizes. The strategy also provides a competitive edge to Indian exporters facing Chinese competition.
Nifty faces stiff resistance near 25,100; sector rotation is key
Markets remain cautious below the 25100 resistance, vulnerable to corrections and volatility. Sector rotation, profit protection, and modest leverage are key amid shifting momentum across